Middletown, DE -- (SBWIRE) -- 09/24/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Interactive Brokers Group, Inc. (NASDAQ:IBKR), EXACT Sciences Corporation (NASDAQ:EXAS), Peregrine Pharmaceuticals (NASDAQ:PPHM), Stereotaxis Inc (NASDAQ:STXS)
Interactive Brokers Group, Inc.(NASDAQ:IBKR) gained volume of 1.10 million shares and the average volume of the stock remained 358,478.00 shares. The 52 week range of the stock remained $13.48 - $18.90 and the day range was $18.48 - $18.90.The stock opened the session at $18.60, and closed the session at $18.89. The stock showed a positive performance of +1.83% in previous trading session. Interactive Brokers Group, Inc. operates as an automated electronic broker and market maker. It engages in routing orders; and executing and processing trades in securities, futures, foreign exchange instruments, bonds, and mutual funds on approximately 100 electronic exchanges and trading venues worldwide.
For How Long IBKR’s Gloss will Attract Investors? Find out via this report
In previous session, EXACT Sciences Corporation (NASDAQ:EXAS) traded 1.20 million shares and the average volume of the stock remained 823,540.00 shares. The 52 week range of the stock remained $6.93 - $14.70. The stock was a bear and dropped -1.46%, while its closing price stayed at $12.19. The market capitalization of the stock remained 861.82 million. The half-yearly trend of the stock remained positive +21.78%. Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Has EXAS Found The Bottom And Ready To Gain Momentum? Find Out Here
Peregrine Pharmaceuticals (NASDAQ:PPHM) volume of the stock was 1.06 million shares in the most recent session and the average volume remained 1.00 million shares. The stock finished the prior session at the closing price of $1.38. The stock traded 1.06 million shares in its previous trading session and its average volume remained 1.00 million shares. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer. The company?s lead product candidates in development include Bavituximab, The company was founded in 1981 and is based in Tustin, California.
Can PPHM Show a Strong Recovery? Find out in This Research Report
Stereotaxis Inc(NASDAQ:STXS) traded with volume of 1.05 million shares and the average volume of the stock remained 1.21 million shares. The stock grew +3.41% and finished the trading at $3.34. The market capitalization of the stock remained 48.89 million. The beta of the stock remained 2.15. Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control system in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to navigate catheters, guidewires, and other delivery devices through the blood vessels and heart chambers to treatment sites.
Why Should Investors Buy STXS After The Recent Gain? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)